NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury

Hecker, Louise, Vittal, Ragini, Jones, Tamara, Jagirdar, Rajesh, Luckhardt, Tracy R, Horowitz, Jeffrey C, Pennathur, Subramaniam, Martinez, Fernando J +1 more·2009·Nature Medicine
DOI 10.1038/nm.2005

Cited by (857)

Items 701–800 of 857

  1. SIRT3/6/7: promising therapeutic targets for pulmonary fibrosis
    Pingping Huang, Qin Du, Yanling Qin, Sha Tao, Guangnan Liu · 2025 · Frontiers in Cell and Developmental Biology
  2. Anti-Fibrotic Therapies from Other Organs: What the Gut Can Learn from the Liver, Skin, Lung and Heart
    Calen A. Steiner, Peter Higgins · 2018 · Springer eBooks
  3. Knockdown of dual oxidase 1 suppresses activin A-induced fibrosis in cardiomyocytes via the reactive oxygen species-dependent pyroptotic pathway
    Shengwei Li, Zhibing Li, Ran Yin, Jungang Nie, Yongnan Fu, Ru Ying · 2020 · The International Journal of Biochemistry & Cell Biology
  4. Therapeutic correlation of NOX4 and diabetes-mediated neurodegeneration
    Chanchal Tiwari, Heena Khan, Amarjot Kaur Grewal, Thakur Gurjeet Singh · 2023 · Obesity Medicine
  5. Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial
    Chang Tang, Lanting Wang, Zihua Chen, Jin Ping Yang, Haiqing Gao, Chenggong Guan, Qiaozhi Gu, Shan He, Fanping Yang, Shengan Chen et al. · 2023 · Therapeutics and Clinical Risk Management
  6. The Effect of Physalis angulata L. Administration on Gene Expressions Related to Lung Fibrosis Resolution in Mice-Induced Bleomycin
    Ummul Imaduddin, Afiat Berbudi, Enny Rohmawaty · 2024 · Journal of Experimental Pharmacology
  7. Innovations thérapeutiques de la fibrose pulmonaire idiopathique
    Y. Uzunhan, Hilario Nunès, Thomas Gille, Camille Bron, Carole Planès, Dominique Valeyre · 2011 · La Presse Médicale
  8. NADPH Oxidases: Structure and Function
    Mark T. Quinn · 2013 · Wiley eBooks
  9. Reply to: "NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis"
    Louise Hecker, David R. Crowe, Victor John Thannickal · 2011 · Nature Medicine
  10. A Redox-Shifted Fibroblast Subpopulation Emerges in the Fibrotic Lung
    Patrick A. Link, Jeffrey A. Meridew, Nunzia Caporarello, Ashley Y. Gao, Victor Peters, Gordon B. Smith, Mauricio Rojas, Daniel J. Tschumperlin · 2024 · American Journal of Respiratory Cell and Molecular Biology
  11. Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship
    Xiaomeng Wang, Ting Jin Zhou, Shaolin Huang, Heting Zhou, Yihan Ling, Tao Chen, Shuwen Zhang, Wenxi Wang, Chuan Wu, Wenya Yin · 2025 · International Immunopharmacology
  12. Transcription factor MEOX1 accelerates pulmonary fibrosis by regulating mitophagy and senescence
    Lijun Fang, Linmao Lyu, Hongyu Zhong, Jiamao Lin, Pengtao Ren, Yu Wang, Yunhong Yin, Mengyu Zhang, Yi-Qing Qu · 2025 · European Journal of Pharmacology
  13. NADPH Oxidase–Derived Reactive Oxygen Species Generation Drives Endothelial-to-Mesenchymal Transition in Human Pulmonary Endothelial Cells Exposed to Sera From Patients With Idiopathic Pulmonary Fibrosis
    Thị Hằng Giang Phan, Anna Maria Posadino, Roberta Giordo, Alessandro Giuseppe Fois, Pietro Pirina, Angelo Zinellu, Ali Hussein Eid, Gianfranco Pintus · 2025 · Journal of Cardiovascular Pharmacology
  14. Persistence of alveolar fibroblast-derived ADAMTS4+ cells in a preclinical model of delayed pulmonary fibrosis resolution
    Mahsa Zabihi, Ali Khadim, Arun Lingampally, Ana Ivonne Vazquez‐Armendariz, Stefan Hadzic, Georgios‐Dimitrios Panagiotidis, Daniel Kalina, Jan Halweg, Tara Procida‐Kowalski, Marek Bartkuhn et al. · 2026 · Nature Communications
  15. The Transforming Growth Factor-Beta (TGF-β) in Liver Fibrosis
    Isabel Fabregat, Patricia Sancho · 2013 · Springer eBooks
  16. Genome-wide DNA methylation analysis of Astragalus and Danshen on the intervention of myofibroblast activation in idiopathic pulmonary fibrosis
    Qingyin Liu, Xue Liu, Guoyu Wang, Fan Wu, Yuan Hou, Huaman Liu · 2023 · BMC Pulmonary Medicine
  17. Investigational gene expression inhibitors for the treatment of idiopathic pulmonary fibrosis
    Paolo Spagnolo, Roberto Tonelli, Marco Mura, William Michael Reisman, Vasilina Sotiropoulou, Argyrios Tzouvelekis · 2025 · Expert Opinion on Investigational Drugs
  18. Fibrogenic gene expression in the skin and lungs of animal model of systemic sclerosis
    Eetmad Abdel-Galil Arafat, Fatma Mohamed Ghoneim, Ayman Zaky Elsamanoudy · 2015 · The Egyptian Journal of Histology
  19. Autoimmune Hepatitis
    Albert J. Czaja · 2017 · Elsevier eBooks
  20. Emerging Concepts in Therapeutic Interventions for Idiopathic Pulmonary Fibrosis
    Cody A. Schott, Michael P. Mohning, Joseph C. Cooley · 2025 · Seminars in Respiratory and Critical Care Medicine
  21. The role of epigenetic regulation in idiopathic pulmonary fibrosis
    Roger M. Li, Maike Stentenbach, Dino B. A. Tan, Herbert P. Ludewick, Eugene Haydn Walters, Britt Clynick, Yuben P. Moodley · 2025 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  22. The immune dysregulation of fibrosis: insights into immune-fibrotic crosstalk and potential therapeutic targets
    Hua-Xin Kang, Yi-Fei Fu, Hao Wu, Xie-Lin Yan, Jun-Jie Wu, Ling-Zhen Jiang, Lei-Sheng Wang, Ya-ru Xiao, Zhen-Zhu Zhang, Feng‐Lai Yuan et al. · 2026 · Frontiers in Immunology
  23. Oxidative Stress in Cardiac Valve Development
    Danielle J. Huk, Joy Lincoln · 2016 · Oxidative stress in applied basic research and clinical practice
  24. Ambulatory oxygen and quality of life in interstitial lung disease
    David B. Page, Victor John Thannickal · 2018 · The Lancet Respiratory Medicine
  25. Strategy of Drug Development Based on the Bioactive Gas-carrying Capacity of Hemoglobin
    Kazuaki Taguchi, Kazuaki Matsumoto, Toru Maruyama, Masaki Otagiri · 2020 · YAKUGAKU ZASSHI
  26. Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients.
    Yuji Iimuro, Akito Yada, Toshihiro Okada, Ikuo Nakamura, Kazuhiro Suzumura, Jinyang Xu, Makoto Sudo, Shuhei Nishiguchi, Norifumi Kawada, Etsuro Hatano et al. · 2020 · PubMed
  27. Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?
    Carmen Veith, Marc Andre Schneider, L.M. Maas, Albert van der Vliet, Frederik‐Jan van Schooten, Michael Kreuter, Michael A. Meister, Agnes W. Boots, Nicolas Carlos Kahn · 2023 · Antioxidants
  28. Epigenetics of the pathogenic myofibroblast in lung disease
    Ksenija Bernau, Nathan K. Sandbo, Allan R. Brasier · 2023 · Elsevier eBooks
  29. Impact of quercetin on pulmonary toxicity induced by diesel exhaust nanoparticles in albino rat : Histological, immunohistochemical and biochemical study
    Eman Mohamed Faruk, Sherifa Abd El-Salam Morsy, Samia Manawy, Hanan Hassan Fouad · 2019 · Journal of Medical Histology/Journal of Medical Histology
  30. NADPH Oxidase in Tissue Repair and Regeneration
    Elsa C. Chan, Guei S. Liu, Carli L. Roulston, Shiang Yong Lim, Gregory James Dusting · 2014 · Springer eBooks
  31. Aging in COPD and Idiopathic Pulmonary Fibrosis
    Cecilia G. Sánchez · 2015 · Springer eBooks
  32. Mécanismes physiopathologiques de la fibrose pulmonaire idiopathique
    Bruno Crestani · 2010 · Bulletin de l Académie Nationale de Médecine
  33. The possible role of milk thistle extract on titanium dioxide nanoparticles-induced lung toxicity in male albino rat
    Nesreen G.A. El Haliem · 2016 · The Egyptian Journal of Histology
  34. Role of Oxidative Stress and Reactive Oxygen Radicals in the Pathogenesis of Systemic Sclerosis
    Sonsoles Piera-Velázquez, Sergio A. Jiménez · 2012 · Springer eBooks
  35. Treatment with Number 2 Feibi Recipe, a Compound Traditional Chinese Medicine Reduces Bleomycin-induced Pulmonary Fibrosis in Mice
    Qi Long, Zhao Heng Liu, Jie Niu, Hao Ge Liu, Xiao Feng Gu, Qinglu Pang, Fang Cao, Jiao Yang · 2021 · Clinical Medicine Research
  36. Pulmonary Fibrosis
    Ramin Rezaee, Hossein Hosseinzadeh · 2021 · Elsevier eBooks
  37. Methyl (5-oxopyrazol-3-yl)acetate N,S-ketene acetal as a new building block for the construction of pyrazolo[4,3-c]pyridines
    M. A. Prezent, S. V. Ruban, S. V. Baranin, Yu. N. Bubnov · 2016 · Russian Chemical Bulletin
  38. Pulmonary Fibrosis and Oxidative Stress
    Corrine R. Kliment, Tim D. Oury · 2014 · Oxidative stress in applied basic research and clinical practice
  39. Fibrotic Signaling in the Lung
    Justin A. Dutta, Harinath Bahudhanapati, Jiangning Tan, Alon Goldblum, Daniel J. Kass · 2018 · Molecular and translational medicine
  40. Circadian clock regulation of myofibroblast fate
    Yoanna Tsoneva, Tsvetelina Veselinova Velikova, Georgi Nikolaev · 2025 · Cellular Signalling
  41. A Comprehensive Review on Pulmonary Fibrosis (PF): Histological Spectrum, Diagnosis, Risk Factors, Pathogenesis, Molecular Pathophysiology, and Current Treatment Options
    Mohamed A. Sadek, Rana M. ElBishbishy, Rana M. Lotfy, Nada Fayez, Ghadir A. Sayed, Riham A. El‐Shiekh, Dina M. Hal · 2025 · Chemistry & Biodiversity
  42. Nitric oxide redox signaling as a convergent mechanism in aging and fibrosis
    Xue Guo, Yubin Cao, Lu Liu, Yangqing Peng, Yu Du, Fan Yang, Dingming Huang · 2026 · Ageing Research Reviews
  43. Aortic Segments‐Depending Hypertensive Remodeling Is Driven by Mitochondrial Fusion Dysfunction
    Adelaide Richard, Alicia Baptista Vicente, Clara Gourhand, Antoine Ducroix, Pauline Robert, Bertrand Toutain, Linda Grimaud, Emilie Vessières, Agnès Barbelivien, Guy Lenaers et al. · 2026 · The FASEB Journal
  44. Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment
    Humayra Afrin, S. Chakraborty, Md Nafiujjaman, Md Nurul Huda, Taeho Kim, Lela Vuković, Yong-Kyu Lee, Md Nurunnabi · 2026 · ACS Applied Bio Materials
  45. Nicotinamide adenine dinucleotide phosphate oxidase 4 in lung disease: a review of its biology and therapeutic potential
    Y Wang, Tianru Ben, Jianjiang Fang, Zengpan Li, Jinhua Ding, Liyan Xu, Kai Lin, Li Jiang · 2026 · Experimental Biology and Medicine
  46. Tanshinone IIA Attenuates Pulmonary Fibrosis via Dual Inhibition of JNK and Smad Signaling
    Congying Guo, Sheng Ai, Jun Chen · 2026 · Antioxidants
  47. Role of Mitochondrial Reactive Oxygen and Nitrogen Species in Respiratory Diseases
    Anantha K. Harijith, Prasad V.S. Kanteti, Panfeng Fu, Sainath R. Kotha, Narasimham L. Parinandi, Viswanathan Natarajan · 2014 · Respiratory medicine
  48. A pair of novel targets
    Charlotte Harrison · 2009 · Nature Reviews Drug Discovery
  49. Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
    Eva Baroke, Shyam S. Maharaj, Martin R.J. Kolb · 2011 · Clinical Investigation
  50. Interstitial Lung Disease 1 New cellular and molecular mechanisms of lung injury and fi brosis in idiopathic pulmonary fi brosis
    Isis E. Fernandez, Oliver Eickelberg · 2012
  51. The Role of NADPH Oxidase in ROS Mediated Differentiation
    Benjamin J. Dickson · 2016 · Scholarship@Western (Western University)
  52. Redox distress in organ fibrosis: The role of noncoding RNAs
    Verónica Miguel, Santiago Lamas · 2019 · Elsevier eBooks
  53. Flaxseed Oil Supplementation Afford Comparable Therapeutic effect to Metformin in Bleomycin Induced Pulmonary Fibrosis Rat model
    Eman Kolieb, Shymaa Ahmed Maher, Karima El-Sayed · 2021 · Bulletin of Egyptian Society for Physiological Sciences
  54. Illuminating the effect of beneficial blue light and ROS-modulating enzymes in Dupuytren’s disease
    Carina Jaekel, Simon Thelen, Lisa Oezel, Marie H. Wohltmann, Julia Wille, Joachim Windolf, Vera Grotheer · 2021 · PLoS ONE
  55. Nox4: From Discovery to Pathophysiology
    Louise Hecker, Kosuke Kato, Kathy K. Griendling · 2023 · Springer eBooks
  56. Restoration of the morphofunctional state of rats lungs with experimental fibrosis through transplanted stem cells
    A. Y. Mazurkevych, Yuliia Surtaieva · 2023 · Agricultural science and practice
  57. TGF-β signaling pathway in the regulations of development and disease
    Hongyao Sun, Sixuan Wei, Qiaoran Xi · 2024 · Chinese Science Bulletin (Chinese Version)
  58. TGF-β in Development and Ageing
    Harris Pratsinis, Eleni Mavrogonatou, Dimitris Kletsas · 2017 · Healthy ageing and longevity
  59. ENERGY SENSING PATHWAYS IN AGING AND CHRONIC LUNG DISEASE.
    Victor John Thannickal · 2020 · PubMed Central
  60. Fibroblast biology in idiopathic pulmonary fibrosis
    Jeffrey Craig Horowitz, Victor John Thannickal · 2015
  61. Translational research on exhaled volatile organic compounds from bedside to bench
    Rianne Fijten · 2017
  62. Redox regulation in pulmonary fibrosis
    Veith · 2019
  63. Constraint-based modeling identifies metabolic vulnerabilities during the epithelial to mesenchymal transition
    Scott Campit, Venkateshwar G. Keshamouni, Sriram Chandrasekaran · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Journal Club
    2009 · Kidney International
  65. Transcriptomic analysis of TGFβ-mediated fibrosis in primary human Tenon’s fibroblasts
    Zoe Pasvanis, Antony Boynes, Roy C. K. Kong, Elsa C. Chan, Raymond C.B. Wong, Jennifer C. Fan Gaskin · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  66. The investigation of intrinsic abnormalities in the airway smooth muscle cells in asthma
    Amanda Sutcliffe · 2014 · Leicester Research Archive (University of Leicester)
  67. Nucleoredoxin and Wnt signaling in F9 cells
    Leanne Sandieson · 2012 · Scholarship@Western (Western University)
  68. ANALYSE STRUCTURALE ET FONCTIONNELLE DE LA NADPH OXYDASE DES NEUTROPHILES : UTILISATION DE LA SPECTROMETRIE DE MASSE POUR CARACTERISER LES CHANGEMENTS CONFORMATIONNELS DE p47phox LORS DE SON ACTIVATION
    Julien Marcoux · 2010 · OpenGrey (Institut de l'Information Scientifique et Technique)
  69. MOLECULAR STUDIES ON LIM-DOMAIN PROTEIN CRP1
    Päivi P. Järvinen · 2011 · Työväentutkimus Vuosikirja
  70. NADPH oxydase Nox4 : structure/fonction protéomique recombinante et approche immunologique
    Leilei Zhang · 2011
  71. Ob(nox)ious fibrosis
    Benjamin Boettner · 2014 · Science-Business eXchange
  72. Original Open Access
    Masakuni Tako, Jyunpei Shimabukuro, Wen Jun Jiang, Masashi Yamada, Hideharu Ishida, Makoto Kiso · 2013
  73. La voie Nrf2 en pathologie
    Anne Boutten, Delphine Goven, Élise Artaud-Macari, Marcel Bonay · 2011
  74. Papel de la transición epitelial mesenquimal en el remodelado bronquiolar de pacientes con EPOC : aproximación clínica y farmacológica
    Teresa Peiró Salvador · 2013
  75. Cytoskeletal Regulation of the Myofibroblast Phenotype: Central Effects on the Primary Cilium and Redox State
    Matthew Rozycki · 2015 · TSpace (University of Toronto)
  76. Transdisciplinary Approaches in the Development of Novel Therapies for the Treatment of Fibrotic Diseases
    Louise Hecker · 2016 · Transdisciplinary Journal of Engineering & Science
  77. Protein thiol oxidoreductas and allergic airways disease
    Sidra M. Hoffman · 2016
  78. PROAGIO (A Protein Designed to Target Integrin ?V?3)
    Ravi Chakra Turaga · 2022 · Digital Archive @ GSU
  79. Aging and idiopathic pulmonary fibrosis
    Marta Bueno, Ana Lucia Mora, Mauricio M. Rojas · 2015
  80. Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery
    Kazuaki Taguchi · 2018 · YAKUGAKU ZASSHI
  81. Characterization of myofibroblasts isolated from the intestine of patients with inflammatory bowel disease
    Serge Dionne, Sophie Restellini, Jamie Koenekoop, Pedro Salvador Escribano, Ciriaco A. Piccirillo, Patrick Charlebois, Alexander Sender Liberman, Barry Stein, Carl Frédéric Duchatellier, Ernest Gerald Seidman · 2019 · F1000Research
  82. NADPH oxidases (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
    Albert van der Vliet · 2019 · IUPHAR/BPS Guide to Pharmacology CITE
  83. Can we distinguish eustress from distress in marine mammals? Trade-offs in expression of molecular stress markers and consequences for cell damage and whole-animal fitness measures in grey seals (Halichoerus grypus)
    Holly C. Armstrong · 2019 · PEARL (University of Plymouth)
  84. Redox mechanisms in pulmonary disease: Emphasis on pulmonary fibrosis
    Yvonne M. W. Janssen-Heininger, Vikas Anathy · 2019 · Elsevier eBooks
  85. Environmental and Occupational agents and Cancer Drug-Induced Oxidative Stress in Pulmonary Fibrosis
    Tapati Chakraborti, Jaganmay Sarkar, Pijush Kanti Pramanik, Sajal Chakraborti · 2019 · Springer eBooks
  86. Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis
    Andrew J. Thorley, Simon Krautwald, David John Rowlands · 2020 · Royal Society of Chemistry eBooks
  87. Epigenetics and Systemic Sclerosis
    Nezam Altorok, Amr H. Sawalha · 2015 · Elsevier eBooks
  88. p22phox y NADPH oxidasas en la hematopoyesis in vivo
    Rodrigo Bermejo · 2020
  89. NADPH oxidases in GtoPdb v.2021.3
    Albert van der Vliet · 2021 · IUPHAR/BPS Guide to Pharmacology CITE
  90. Development of a bioactive gas delivery strategy based on biomimetic red blood cells for the treatment of intractable diseases
    Kazuaki Taguchi · 2021 · Drug Delivery System
  91. Faculty Opinions recommendation of Reversible differentiation of myofibroblasts by MyoD.
    Giulio Gabbiani · 2011 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  92. Interaction Between Epithelial and Mesenchymal Cells in Interstitial Lung Disease
    Max Cohen, Paul J. Wolters · 2020 · Elsevier eBooks
  93. Mechanisms of Fibrosis in IPF
    Nathan K. Sandbo · 2018 · Respiratory medicine
  94. Faculty Opinions recommendation of PU.1 controls fibroblast polarization and tissue fibrosis.
    Jagdeep Nanchahal · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  95. Faculty Opinions recommendation of Metformin reverses established lung fibrosis in a bleomycin model.
    Vassilis Aidinis, Christiana Magkrioti · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  96. Quo Vadis NADPH Oxidases: Perspectives on Clinical Translation
    Ulla G. Knaus, Ajay M. Shah, Victor John Thannickal · 2023 · Springer eBooks
  97. NADPH oxidases in GtoPdb v.2023.3
    Albert van der Vliet · 2023 · IUPHAR/BPS Guide to Pharmacology CITE
  98. WITHDRAWN: Targeting CAFs
    Katie O’Fee, Amy Burley, Anna Clare Wilkins · 2024 · Elsevier eBooks
  99. Targeting CAFs
    Katie O’Fee, Amy Burley, Anna Clare Wilkins · 2024 · Elsevier eBooks
  100. Fibrogenic Irritants
    Jennifer L. Larson‐Casey, NHI N VU-TICAR, John Craver, Christopher T. Migliaccio, Andrij Holian, Rebekah L. Kendall, Jacob M. Albright, Alessandro Venosa · 2024 · Elsevier eBooks